Tobacco smoking as a risk factor of bronchioloalveolar carcinoma of the lung: pooled analysis of seven case-control studies in the International Lung Cancer Consortium (ILCCO)
- PMID: 21072579
- PMCID: PMC3002160
- DOI: 10.1007/s10552-010-9676-5
Tobacco smoking as a risk factor of bronchioloalveolar carcinoma of the lung: pooled analysis of seven case-control studies in the International Lung Cancer Consortium (ILCCO)
Abstract
Background: The International Lung Cancer Consortium (ILCCO) was established in 2004, based on the collaboration of research groups leading large molecular epidemiology studies of lung cancer that are ongoing or have been recently completed. This framework offered the opportunity to investigate the role of tobacco smoking in the development of bronchioloalveolar carcinoma (BAC), a rare form of lung cancer.
Methods: Our pooled data comprised seven case-control studies from the United States, with detailed information on tobacco smoking and histology, which contributed 799 cases of BAC and 15,859 controls. We estimated the odds ratio of BAC for tobacco smoking, using never smokers as a referent category, after adjustment for age, sex, race, and study center.
Results: The odds ratio of BAC for ever smoking was 2.47 (95% confidence interval [CI] 2.08, 2.93); the risk increased linearly with duration, amount, and cumulative cigarette smoking and persisted long after smoking cessation. The proportion of BAC cases attributable to smoking was 0.47 (95% CI 0.39, 0.54).
Conclusions: This analysis provides a precise estimate of the risk of BAC for tobacco smoking.
Figures
References
-
- The Health Consequences of Smoking (2004) A report of the Surgeon General. Office on Smoking and Health, DHHS Washington, DC
-
- Muscat JE, Stellman SD, Zhang ZF, Neugut AI, Wynder EL. Cigarette smoking and large cell carcinoma of the lung. Cancer Epidemiol Biomarkers Prev. 1997;6:477–480. - PubMed
-
- Colby TV, Noguchi M, Henschke C, Vazquez MF, Geisinger K, Yokose T, et al. Adenocarcinoma. In: Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC, et al., editors. World health classification of tumours pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004. pp. 35–44.
-
- Falk RT, Pickle LW, Fontham ET, Greenberg SD, Jacobs HL, Correa P, et al. Epidemiology of bronchioloalveolar carcinoma. Cancer Epidemiol Biomarkers Prev. 1992;1:339–344. - PubMed
Publication types
MeSH terms
Grants and funding
- P01 CA068384/CA/NCI NIH HHS/United States
- R01 CA084354/CA/NCI NIH HHS/United States
- R01CA60691/CA/NCI NIH HHS/United States
- R01 CA074386/CA/NCI NIH HHS/United States
- R01CA90833/CA/NCI NIH HHS/United States
- CA-29580/CA/NCI NIH HHS/United States
- P30CA22453/CA/NCI NIH HHS/United States
- P30 CA017613/CA/NCI NIH HHS/United States
- CA-68384/CA/NCI NIH HHS/United States
- NIH-CA 80127/CA/NCI NIH HHS/United States
- CA-17613/CA/NCI NIH HHS/United States
- NIH R01DA11386/DA/NIDA NIH HHS/United States
- R01CA092824/CA/NCI NIH HHS/United States
- P20 CA090578/CA/NCI NIH HHS/United States
- R01 CA092824/CA/NCI NIH HHS/United States
- R01 CA087895/CA/NCI NIH HHS/United States
- R01CA55874/CA/NCI NIH HHS/United States
- R01 CA060691/CA/NCI NIH HHS/United States
- NIH CA-32617/CA/NCI NIH HHS/United States
- P20CA090578/CA/NCI NIH HHS/United States
- NIH-CA 77118/CA/NCI NIH HHS/United States
- R01 DA011386/DA/NIDA NIH HHS/United States
- R01CA074386/CA/NCI NIH HHS/United States
- R01CA87895/CA/NCI NIH HHS/United States
- R01 CA080127/CA/NCI NIH HHS/United States
- NIH-CA 84354/CA/NCI NIH HHS/United States
- P30 CA022453/CA/NCI NIH HHS/United States
- R03 CA077118/CA/NCI NIH HHS/United States
- R01 CA090833/CA/NCI NIH HHS/United States
- N01 PC035145/CA/NCI NIH HHS/United States
